• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估化学毒性测试的不确定性、持续时间和成本相关权衡的信息价值框架。

A value of information framework for assessing the trade-offs associated with uncertainty, duration, and cost of chemical toxicity testing.

机构信息

Risk Sciences International, Ottawa, Canada.

School of Mathematics and Statistics, Carleton University, Ottawa, Canada.

出版信息

Risk Anal. 2023 Mar;43(3):498-515. doi: 10.1111/risa.13931. Epub 2022 Apr 22.

DOI:10.1111/risa.13931
PMID:35460101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10515440/
Abstract

A number of investigators have explored the use of value of information (VOI) analysis to evaluate alternative information collection procedures in diverse decision-making contexts. This paper presents an analytic framework for determining the value of toxicity information used in risk-based decision making. The framework is specifically designed to explore the trade-offs between cost, timeliness, and uncertainty reduction associated with different toxicity-testing methodologies. The use of the proposed framework is demonstrated by two illustrative applications which, although based on simplified assumptions, show the insights that can be obtained through the use of VOI analysis. Specifically, these results suggest that timeliness of information collection has a significant impact on estimates of the VOI of chemical toxicity tests, even in the presence of smaller reductions in uncertainty. The framework introduces the concept of the expected value of delayed sample information, as an extension to the usual expected value of sample information, to accommodate the reductions in value resulting from delayed decision making. Our analysis also suggests that lower cost and higher throughput testing also may be beneficial in terms of public health benefits by increasing the number of substances that can be evaluated within a given budget. When the relative value is expressed in terms of return-on-investment per testing strategy, the differences can be substantial.

摘要

许多研究人员已经探索了使用信息价值(Value of Information,VOI)分析来评估不同决策背景下替代信息收集程序的方法。本文提出了一个用于确定风险决策中使用的毒性信息价值的分析框架。该框架专门用于探索不同毒性测试方法之间与成本、及时性和不确定性减少相关的权衡。通过两个说明性应用程序演示了所提出框架的使用,尽管基于简化的假设,但这些应用程序展示了通过使用 VOI 分析可以获得的见解。具体而言,这些结果表明,信息收集的及时性对化学毒性测试的 VOI 估计有重大影响,即使不确定性的减少较小也是如此。该框架引入了延迟样本信息的预期价值的概念,作为通常样本信息的预期价值的扩展,以适应由于延迟决策而导致的价值降低。我们的分析还表明,更低的成本和更高的吞吐量测试也可能通过增加在给定预算内可以评估的物质数量而有益于公共健康效益。当相对价值以每个测试策略的投资回报率表示时,差异可能很大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/d7ff7671072d/nihms-1894119-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/72b71e28c462/nihms-1894119-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/285a0c572322/nihms-1894119-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/1a1b45de981a/nihms-1894119-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/d7ff7671072d/nihms-1894119-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/72b71e28c462/nihms-1894119-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/285a0c572322/nihms-1894119-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/1a1b45de981a/nihms-1894119-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10515440/d7ff7671072d/nihms-1894119-f0004.jpg

相似文献

1
A value of information framework for assessing the trade-offs associated with uncertainty, duration, and cost of chemical toxicity testing.一种用于评估化学毒性测试的不确定性、持续时间和成本相关权衡的信息价值框架。
Risk Anal. 2023 Mar;43(3):498-515. doi: 10.1111/risa.13931. Epub 2022 Apr 22.
2
When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.多少证据才算足够?——运用系统决策分析和信息价值分析来确定是否需要更多证据。
Z Evid Fortbild Qual Gesundhwes. 2013;107(9-10):575-84. doi: 10.1016/j.zefq.2013.10.020. Epub 2013 Nov 12.
3
Microsimulation Estimates of Decision Uncertainty and Value of Information Are Biased but Consistent.决策不确定性和信息价值的微观模拟估计存在偏差但具有一致性。
Med Decis Making. 2025 Feb;45(2):127-142. doi: 10.1177/0272989X241305414. Epub 2024 Dec 25.
4
The value of information for managing contaminated sediments.管理污染沉积物的信息价值。
Environ Sci Technol. 2014 Aug 19;48(16):9478-85. doi: 10.1021/es500717t. Epub 2014 Jul 21.
5
A Value-of-Information Framework for Personalizing the Timing of Surveillance Testing.用于个性化监测测试时间的信息价值框架。
Med Decis Making. 2022 May;42(4):474-486. doi: 10.1177/0272989X211049213. Epub 2021 Nov 7.
6
Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.价值信息分析方法:ISPOR 价值信息分析新兴良好实践工作组报告 2 号。
Value Health. 2020 Mar;23(3):277-286. doi: 10.1016/j.jval.2020.01.004.
7
The cost-effectiveness of testing for hepatitis C in former injecting drug users.对曾经注射吸毒者进行丙型肝炎检测的成本效益分析。
Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93. doi: 10.3310/hta10320.
8
A Framework that Considers the Impacts of Time, Cost, and Uncertainty in the Determination of the Cost Effectiveness of Toxicity-Testing Methodologies.一种考虑时间、成本和不确定性影响的框架,用于确定毒性测试方法的成本效益。
Risk Anal. 2022 Apr;42(4):707-729. doi: 10.1111/risa.13810. Epub 2021 Sep 7.
9
Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information.面对不确定性制定药物审批决策:累积证据与信息价值。
Med Decis Making. 2024 Jul;44(5):512-528. doi: 10.1177/0272989X241255047. Epub 2024 Jun 3.
10
Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.信息价值分析在研究决策中的应用:ISPOR 信息价值分析新兴良好实践工作组报告 1。
Value Health. 2020 Feb;23(2):139-150. doi: 10.1016/j.jval.2020.01.001.

引用本文的文献

1
Incorporating new approach methods (NAMs) data in dose-response assessments: The future is now!将新方法(NAMs)数据纳入剂量反应评估:未来已来!
J Toxicol Environ Health B Crit Rev. 2025 Jan 2;28(1):28-62. doi: 10.1080/10937404.2024.2412571. Epub 2024 Oct 10.
2
Progress in toxicogenomics to protect human health.毒理基因组学在保护人类健康方面的进展。
Nat Rev Genet. 2025 Feb;26(2):105-122. doi: 10.1038/s41576-024-00767-1. Epub 2024 Sep 2.
3
Adverse effects in traditional and alternative toxicity tests.传统和替代毒性测试中的不良反应。

本文引用的文献

1
Principles of risk decision-making.风险决策原则
J Toxicol Environ Health B Crit Rev. 2022 Jul 4;25(5):250-278. doi: 10.1080/10937404.2022.2107591. Epub 2022 Aug 18.
2
A Framework that Considers the Impacts of Time, Cost, and Uncertainty in the Determination of the Cost Effectiveness of Toxicity-Testing Methodologies.一种考虑时间、成本和不确定性影响的框架,用于确定毒性测试方法的成本效益。
Risk Anal. 2022 Apr;42(4):707-729. doi: 10.1111/risa.13810. Epub 2021 Sep 7.
3
Exposure and Toxicity Characterization of Chemical Emissions and Chemicals in Products: Global Recommendations and Implementation in USEtox.
Regul Toxicol Pharmacol. 2024 Mar;148:105579. doi: 10.1016/j.yrtph.2024.105579. Epub 2024 Feb 1.
4
Cutting-edge computational chemical exposure research at the U.S. Environmental Protection Agency.美国环保署的前沿计算化学暴露研究。
Environ Int. 2023 Aug;178:108097. doi: 10.1016/j.envint.2023.108097. Epub 2023 Jul 13.
5
Development of an Evidence-Based Risk Assessment Framework.基于证据的风险评估框架的制定。
ALTEX. 2022;39(4):667-693. doi: 10.14573/altex.2004041. Epub 2022 Sep 1.
产品中化学排放物和化学品的暴露与毒性特征:全球建议及在USEtox中的实施
Int J Life Cycle Assess. 2021 May;26(5):899-915. doi: 10.1007/s11367-021-01889-y. Epub 2021 Apr 5.
4
Variability in studies: Defining the upper limit of performance for predictions of systemic effect levels.研究中的变异性:确定全身效应水平预测的性能上限。
Comput Toxicol. 2020 Aug 1;15(August 2020):1-100126. doi: 10.1016/j.comtox.2020.100126.
5
Guidance on the use of the Threshold of Toxicological Concern approach in food safety assessment.食品安全评估中毒理学关注阈值方法的使用指南。
EFSA J. 2019 Jun 6;17(6):e05708. doi: 10.2903/j.efsa.2019.5708. eCollection 2019 Jun.
6
Evaluation of 5-day In Vivo Rat Liver and Kidney With High-throughput Transcriptomics for Estimating Benchmark Doses of Apical Outcomes.高通量转录组学评价大鼠 5 天体内肝、肾,用于估算顶极终点的基准剂量。
Toxicol Sci. 2020 Aug 1;176(2):343-354. doi: 10.1093/toxsci/kfaa081.
7
A Rat Liver Transcriptomic Point of Departure Predicts a Prospective Liver or Non-liver Apical Point of Departure.大鼠肝脏转录组起始点可预测潜在的肝脏或非肝脏顶端起始点。
Toxicol Sci. 2020 Jul 1;176(1):86-102. doi: 10.1093/toxsci/kfaa062.
8
Toxicity testing in the 21st century: progress in the past decade and future perspectives.二十一世纪的毒性测试:过去十年的进展与未来展望。
Arch Toxicol. 2020 Jan;94(1):1-58. doi: 10.1007/s00204-019-02613-4. Epub 2019 Dec 17.
9
Developing context appropriate toxicity testing approaches using new alternative methods (NAMs).开发使用新型替代方法(NAMs)的具有适当背景的毒性测试方法。
ALTEX. 2019;36(4):523-534. doi: 10.14573/altex.1906261.
10
Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.体外生物活性作为体内不良效应水平的下限估计值在基于风险的优先级排序中的应用。
Toxicol Sci. 2020 Jan 1;173(1):202-225. doi: 10.1093/toxsci/kfz201.